Top

RATG: Prospective Phase II Pilot study of Rabbit Antithymocyte globulin (ATG, Thymoglobuline®, Genzyme) with Ciclosporin for Patients with Acquired Aplastic Anaemia and comparison with matched historical patients treated with horse ATG and Ciclosporin

Type d'étude:

Clinical Trials Phase I-III

Numéro de l'étude:

2007-00902-55

Type de traitement à base de cellules souches:

Maladies:

Bone marrow failure

Titre court:

RATGAA07

Objectif principal:

Assess tolerability and efficacy of rabbit ATG (Thymoglobuline®) with CSA in the first line treatment of patients with acquired SAA, and patients with NSAA

Principaux critères d'inclusion:

>=16years (18 in DE + CH)

Pays:

France

Allemagne

Italie

Arabie Saoudite

Suisse

Royaume Uni

Investigateur principal:

Judith Marsh

Coordinateur EBMT de l'étude:

Alain Barrois

http://www.clinicaltrials.gov/ct2/show/NCT00471848?term=RATGAA07&rank=1